Description

ITPP Myo-Inositol – Product Information

ITTP or Myo-inositol trispyrophospate is a research compound currently being investigated in hopes of aiding patients weakened by myocardial infarctions due to its ability to increase oxygen supply to weakened or damaged cardiac muscle.

Designed to make hemoglobin increase its release of oxygen above normal levels, ITPP has the potential ability to boost exercise levels in ailing mice by up to 35% when given dissolved in water. When administered via injection into the abdomen, exercise levels saw potential rise up to a massive 60%. Further research is warranted to investigate the potential of ITPP in oxygen transport and endurance training.

The ITPP Myo-Inositol for sale from PureRawz is strictly for laboratory research use only and is not for human consumption.

ITPP
CAS Number	623552-11-4
Molar Mass	605.984 g·mol−1
Chemical Formula	C6H12O21P6
IUPAC Name	4,6,11,13,18,20-hexahydroxy-3,5,7,10,12,14,17,19,21-nonaoxa-4λ5,6λ5,11λ5,13λ5,18λ5,20λ5-hexaphosphatetracyclo[14.5.0.02,8.09,15]henicosane 4,6,11,13,18,20-hexaoxide

What is ITPP?

The ITPP Myo Inositol Trispyrophosphate is a synthetic substance created from the antioxidant and anti-cancer chemical Myo Inositol Hexakisphosphate, typically synthesized in mammalian cells.

In laboratory settings, ITPP may be administered orally or via intravenous injection.

This research chemical is still under investigation and is not recommended for human consumption. Buying ITPP Myo Inositol Trispyrophosphate should only be for research purposes.

ITPP is commonly viewed as a drug that could improve performance in racehorses, but this is not allowed by the FDA. Most professional sports, including horse racing, forbid Myo Inositol Trispyrophosphate ITPP.

Potential Applications of ITPP

ITPP and Hypoxia

Some researchers are investigating the impact of ITPP injection on hypoxia, a condition when tissues do not receive enough oxygen in the body.

The reason behind this is that ITPP can provide regulated oxygen-releasing capacity among red blood cells.

Angiogenesis, or the growth of new blood vessels, is an indication of hypoxia. In order to provide more oxygen to hypoxic tissues, the body automatically speeds up angiogenesis. [R]

Based on cell research, ITPP may lessen the presence of VEGF and hypoxia-inducible factor 1alpha, which are known hypoxia indicators. [R] The same study even concluded ITTP’s capability to reduce angiogenesis.

In this study, researchers discovered ITPP’s potential to lessen red blood cells’ capacity to bind oxygen coupled with RBCs boosting oxygen transport to tissues. [R]

ITPP and Exercise Capacity

One of the most well-known investigations of ITPP was carried out by Jean-Marie Lehn, a professor of supramolecular chemistry at the University of Strasbourg in France. [R]

The ITPP medication was dissolved in water and given to mice with damaged hearts to consume.

After consuming the mixture, the mice’s ability to exercise increased by 35%. Even more impressive is the fact that when ITPP was administered via slow intravenous into the abdomen of the mice, they displayed increased energy by 60%.

The above result indicates that Myo-Inositol Trispyrophosphate dosage increases the maximal exercise capacity among mammals.

Additionally, some mouse studies indicate that ITPP delivered orally or through intramuscular injection may enhance exercise. [R]

ITPP and Cancer

Angiogenesis, or the development of new blood vessels, is one of the impacts of hypoxia (low oxygen levels).

Angiogenesis even has the ability to accelerate tumor growth and aid in the metastasis of cancer cells (spread to other body organs). [R]

The synthetic allosteric effector (ITPP) may have anti-cancer effects by reducing hypoxia and angiogenesis, according to a number of animal and cell experiments.

According to research, the abovementioned effect may lessen the chance of metastasis and tumor growth. [R] [R]

Mechanisms of Action for ITPP

Hemoglobin’s allosteric effector, ITPP, makes more oxygen available to tissues. In other words, ITPP improves red blood cells’ capacity to deliver oxygen to tissues rather than doing so directly.

Additionally, ITPP is an inositol phosphate. The latter is a class of compounds involved in cellular function and signaling. [R]

ITPP operates by binding to the membrane of red blood cells (hemoglobin), wherein the cells eventually release oxygen. [R] This attribute makes ITTP an allosteric effector of hemoglobin.

Another research concludes that by increasing oxygen delivery, the expected outcome is improved muscle function and activity. There is also evidence from animal studies that ITPP can provide anti-cancer properties, though no human studies have been conducted. [R]

Does ITPP have Side Effects?

There is no information available about ITPP’s safety. ITPP has no known side effects to date which means more research is needed to further understand its effects on humans.

Frequently Asked Questions

What other research chemicals work well with ITPP?

Cardarine may work well with ITPP powder in research.

Where can you buy ITPP online?

PureRawz is a company based in the United States that sells SARMs and other research chemicals online, including ITPP They, like all other SARMs sellers, only sell these compounds as research products.